Earlier onset of Alzheimer's disease in men with Down syndrome

Neurology

Volumn 50, Issue 4, 1998, Pages 991-995

  Schupf, N ^a,b   Kapell, D ^a   Nightingale, B ^a   Rodriguez, A ^a,b   Tycko, B ^c   Mayeux, R ^b,d,e  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b and Epidemiology   (United States)

^c Columbia Univ Sch of Public Health ^*  (United States)

^d New York State Psychiatric Institute   (United States)

^e The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0031948289     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.991     Document Type: Article

References (35)

1. Mann DMA. The pathological association between Down syndrome and Alzheimer disease. Mech Aging Devel 1988;43:99-136.
2. Wisniewski HM, Weigel J, Popovitch ER. Age-associated development of diffuse and thioflavin-S-positive plaques in Down syndrome. Dev Brain Dysfunct 1994;7:330-339.
3. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-853.
4. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-119.
5. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
6. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991;41:1886-1891.
7. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology 1993;43:515-519.
8. Schoenberg GD, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987;22:724-729.
9. Kokmen E, Chandra V, Schoenberg B. Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 1988;38:975-980.
10. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132-138.
11. Martin CR. Endocrine physiology. New York: Oxford University Press, 1985.
12. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology 1988;39: 207-212.
13. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E4 and gender. JAMA 1994;271:1316-1317.
14. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-811.
15. Corder EH, Saunders AM, Strittmatter WJ, Haines J, Pericak-Vance MS, Roses AD. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
16. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754.
17. Hyman BT, West HL, Rebeck GW, et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Nat Acad Sci USA 1995;92:3586-3590.
18. Schupf N, Kapell D, Lee JH, Ottman, Mayeux R. Increased risk of Alzheimer's disease in mothers of adults with Down syndrome. Lancet 1994;344:353-356.
19. Jorde LB, Carey JC, White RL. Medical genetics 1995. New York: Mosby, 1995:109.
20. Percy ME, Markovic VD, Dalton AJ, et al. Age-associated chromosome 21 loss in Down syndrome: possible relevance to mosaicism and Alzheimer disease. Am J Med Genet 1993;45: 584-588.
21. Jenkins EC, Schupf N, Genevese M, et al. Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome. Am J Med Genet 1997;68:147-151.
22. Hardy J, Crook R, Perry R, Raghavan R, Roberts G. APOE genotype and Down's syndrome. Lancet 1994;343:979-980.
23. Royston MC, Mann D, Pickering-Brown S, et al. Apolipoprotein E ∈2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport 1994;5:2583-2585.
24. Toran-Allerand CD, Miranda R, Bentham W, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992;89:4668-4672.
25. Rainbow TC, DeGroff V, Luine VN, McEwen BS. Estradiol 17-beta increases the number of muscarinic receptors in hypothalamic nuclei. Brain Res 1980;198:239-243.
26. Simpkins J, Meharvan S, Bishop J. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 1994;15(suppl 2):5195-5197.
27. Jaffe A, Toran-Allerand CD, Greengard P, Gandy S. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994;269:13065-13068.
28. Tang MX, Jacobs D, Stern Y, et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
29. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140: 256-261.
30. Henderson VW, Paganini-Hill A, Emmanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women. Arch Neurol 994;51:896-900.
31. Honjo H, Tanaka K, Kashiwag T, et al. Senile dementia-Alzheimer's type and estrogen. Horm Metab Res 1995;27:204-207.
32. Campbell WA, Lowther J, McKenzie I, Price WH. Serum gonadotrophins in Down's syndrome. J Med Genet 1982;19:98-99.
33. Hsiang Y-HH, Berkovitz GD, Bland GL, Migeon CJ, Warren AC. Gonadal function in patients with Down syndrome. Am J Med Genet 1987;27:449-458.
34. Hasen J, Boyar RM, Shapiro LR. Gonadal function in trisomy 21. Hormone Res 1980;12:345-350.
35. Hestnes A, Stovener LJ, Husoy O, Folling I, Fougner KJ, Sjaastad O. Hormonal and biochemical disturbances in Down's syndrome. J Ment Defic Res 1991;35:179-193.